Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 5201 - 5225 of 6650 in total
Experimental
Matched Iupac: … (2S)-5-amino-2-(3-carboxypropanamido)pentanoic acid …
Experimental
Matched Iupac: … N-[2-(1H-imidazol-5-yl)ethyl]acetamide …
Dehydroascorbic acid is made from the oxidation of ascorbic acid. This reaction is reversible, but dehydroascorbic acid can instead undergo irreversible hydrolysis to 2,3-diketogulonic acid. Dehydroascorbic acid as well as ascorbic acid are both termed Vitamin C, but the latter is the main form found in humans. In the body,...
Experimental
Matched Iupac: … (5R)-5-[(1S)-1,2-dihydroxyethyl]oxolane-2,3,4-trione …
L-NAME has been investigated for the treatment of Hypotension and Spinal Cord Injury.
Investigational
Matched Iupac: … methyl (2S)-2-amino-5-(N'-nitrocarbamimidamido)pentanoate …
An2718 has been used in trials studying Tinea Pedis.
Investigational
Matched Iupac: … 5-chloro-1,3-dihydro-2,1-benzoxaborol-1-ol …
Eltoprazine has been used in trials studying the treatment of Schizophrenia and Cognitive Impairment.
Investigational
Matched Iupac: … 1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine …
Experimental
Matched Iupac: … 3-[(4-amino-2,6-dimethylpyrimidin-5-yl)methyl]-5-(2-{[(hydrogen phosphonatooxy)(hydroxy)phosphoryl]oxy …
Experimental
Matched Iupac: … (2S,5R,6R)-6-[(5S)-5-amino-5-carboxypentanamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane …
Azvudine is under investigation in clinical trial NCT04668235 (Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (Sars-cov-2 Infected)).
Investigational
Matched Iupac: … 4-amino-1-[(2R,3S,4R,5R)-5-azido-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin …
Investigational
Matched Iupac: … N-(3-{6-amino-5-[2-(N-methylprop-2-enamido)ethoxy]pyrimidin-4-yl}-5-fluoro-2-methylphenyl)-4-cyclopropyl …
Experimental
Matched Iupac: … N-[3-(dimethyl-oxo-$l^{5}-azanyl)propyl]dodecanamide …
Experimental
Investigational
Matched Iupac: … (2S,3S,4S,5R)-5-(hydroxymethyl)oxolane-2,3,4-triol …
Experimental
Matched Iupac: … 6-(3-hydroxypropyl)-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione …
Experimental
Matched Iupac: … (2S)-5-carbamimidamido-2-[(2-carboxyethyl)amino]pentanoic acid …
Experimental
Matched Iupac: … 5-(1,4-diazepane-1-sulfonyl)-1,2-dihydroisoquinolin-1-one …
Gemcabene is a new drug that lowers low-density lipoprotein cholesterol (LDL-C), decreases triglycerides, and raises high-density lipoprotein cholesterol (HDL-C).
Investigational
Matched Iupac: … 6-[(5-carboxy-5,5-dimethylpentyl)oxy]-2,2-dimethylhexanoic acid …
Acifluorfen is a protoporphyrinogen oxidase inhibitor.
Experimental
Matched Iupac: … 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid …
Experimental
Matched Iupac: … methyl (3S)-3-(3-carbamimidoylphenyl)-5-(4-carbamimidoylphenyl)pentanoate …
Nebicapone is under investigation in clinical trial NCT03097211 (Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg).
Investigational
Matched Iupac: … 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenylethan-1-one …
Experimental
Matched Iupac: … 4-chloro-2-methyl-5-(propan-2-yl)phenol …
Experimental
Matched Iupac: … 5-methyl-2-(propan-2-yl)cyclohexan-1-one …
Experimental
Matched Iupac: … 3-(2-{[(2Z)-3-(2-carboxyethyl)-5-{[(2Z)-4-ethenyl-3-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene]methyl ... }-4-methyl-2H-pyrrol-2-ylidene]methyl}-5-{[(2Z)-3-ethenyl-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene …
Experimental
Matched Iupac: … (2S,3R,4R,5S,6R)-5-{[(2R,3R,4R,5S,6R)-5-{[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-{[(1S,2S,3S,4R,5R ... )-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]amino}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan …
Displaying drugs 5201 - 5225 of 6650 in total